COMPASS and SWI/SNF complexes in development and disease

BK Cenik, A Shilatifard - Nature Reviews Genetics, 2021 - nature.com
Abstract The Trithorax group (TrxG) of proteins is a large family of epigenetic regulators that
form multiprotein complexes to counteract repressive developmental gene expression …

Modes of interaction of KMT2 histone H3 lysine 4 methyltransferase/COMPASS complexes with chromatin

A Bochynska, J Lüscher-Firzlaff, B Lüscher - Cells, 2018 - mdpi.com
Regulation of gene expression is achieved by sequence-specific transcriptional regulators,
which convey the information that is contained in the sequence of DNA into RNA …

Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases

D Dixit, BC Prager, RC Gimple, TE Miller… - Science Translational …, 2022 - science.org
Glioblastomas are universally fatal cancers and contain self-renewing glioblastoma stem
cells (GSCs) that initiate tumors. Traditional anticancer drug discovery based on in vitro …

The complex activities of the SET1/MLL complex core subunits in development and disease

H Jiang - Biochimica et Biophysica Acta (BBA)-Gene Regulatory …, 2020 - Elsevier
In mammalian cells, the SET1/MLL complexes are the main writers of the H3K4 methyl mark
that is associated with active gene expression. The activities of these complexes are …

[HTML][HTML] Histone–lysine N-methyltransferase 2 (KMT2) complexes–a new perspective

E Poreba, K Lesniewicz, J Durzynska - Mutation Research/Reviews in …, 2022 - Elsevier
Abstract Histone H3 Lys4 (H3K4) methylation is catalyzed by the Histone–Lysine N-
Methyltransferase 2 (KMT2) protein family, and its members are required for gene …

Aberrant activity of histone–lysine n-methyltransferase 2 (Kmt2) complexes in oncogenesis

E Poreba, K Lesniewicz, J Durzynska - International journal of molecular …, 2020 - mdpi.com
KMT2 (histone-lysine N-methyltransferase subclass 2) complexes methylate lysine 4 on the
histone H3 tail at gene promoters and gene enhancers and, thus, control the process of …

[HTML][HTML] SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells

ML Jin, L Yang, KW Jeong - Theranostics, 2022 - ncbi.nlm.nih.gov
Abstract Rationale: Approximately 30-40% of estrogen receptor (ER)-positive breast cancer
(BC) cases recur after tamoxifen therapy. Thus, additional studies on the mechanisms …

[HTML][HTML] DPY30 promotes proliferation and cell cycle progression of colorectal cancer cells via mediating H3K4 trimethylation

WC Su, XM Mao, SY Li, CY Luo, R Fan… - … journal of medical …, 2023 - ncbi.nlm.nih.gov
DPY30, a core subunit of the SET1/MLL histone H3K4 methyltransferase complexes, plays
an important role in diverse biological functions through the epigenetic regulation of gene …

A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma

C Wu, HF Zhang, N Gupta, A Alshareef, Q Wang… - Journal of hematology & …, 2016 - Springer
Background We have previously described the existence of two phenotypically distinct cell
subsets in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL) based on their …

Chidamide tablets: HDAC inhibition to treat lymphoma.

Y Xu, P Zhang, Y Liu - Drugs of Today (Barcelona, Spain: 1998), 2017 - europepmc.org
Chidamide is the first oral subtype-selective histone deacetylase inhibitor (HDACI) approved
in China as well as the first HDACI of the benzamide class approved for the treatment of …